Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Onestream (OS) Reports Q3 Earnings: What Key Metrics Have to Say
Onestream (OS) Reports Q3 Earnings: What Key Metrics Have to Say

Onestream (OS) reported $154.3 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 19.5%. EPS of $0.08 for the same period compares to -$1.06 a year

Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, 10x Genomics (TXG) reported revenue of $149 million, down 1.8% over the same period last year. EPS came in at -$0.22, compared to -$0.30 in the year-ago

Celanese (CE) Reports Q3 Earnings: What Key Metrics Have to Say
Celanese (CE) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Celanese (CE) reported revenue of $2.42 billion, down 8.7% over the same period last year. EPS came in at $1.34, compared to $2.44 in the year-ago quarter.

The

Morgan Stanley Direct Lending Fund (MSDL) Tops Q3 Earnings and Revenue Estimates
Morgan Stanley Direct Lending Fund (MSDL) Tops Q3 Earnings and Revenue Estimates

Morgan Stanley Direct Lending Fund (MSDL) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.66 per share a

Inseego (INSG) Lags Q3 Earnings Estimates
Inseego (INSG) Lags Q3 Earnings Estimates

Inseego (INSG) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to a loss of $0.07 per share a year ago. These figures are

CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates
CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.07 per share a year ago. These

Compared to Estimates, Doximity (DOCS) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Doximity (DOCS) Q2 Earnings: A Look at Key Metrics

Doximity (DOCS) reported $168.53 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 23.2%. EPS of $0.45 for the same period compares to $0.30 a year

Figs (FIGS) Reports Q3 Earnings: What Key Metrics Have to Say
Figs (FIGS) Reports Q3 Earnings: What Key Metrics Have to Say

Figs (FIGS) reported $151.66 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 8.2%. EPS of $0.05 for the same period compares to -$0.01 a year ago.

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.59 per share a year ago. These

Compared to Estimates, BILL Holdings (BILL) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, BILL Holdings (BILL) Q1 Earnings: A Look at Key Metrics

For the quarter ended September 2025, BILL Holdings (BILL) reported revenue of $395.74 million, up 10.4% over the same period last year. EPS came in at $0.61, compared to $0.63 in the year-ago

Topgolf Callaway (MODG) Reports Q3 Earnings: What Key Metrics Have to Say
Topgolf Callaway (MODG) Reports Q3 Earnings: What Key Metrics Have to Say

Topgolf Callaway Brands (MODG) reported $934 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 7.8%. EPS of -$0.05 for the same period compares to

Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say
Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say

Chemours (CC) reported $1.5 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.4%. EPS of $0.20 for the same period compares to $0.40 a year ago.

The

Barings BDC (BBDC) Beats Q3 Earnings and Revenue Estimates
Barings BDC (BBDC) Beats Q3 Earnings and Revenue Estimates

Barings BDC (BBDC) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.29 per share a year ago. These

Alta Equipment (ALTG) Reports Q3 Loss, Misses Revenue Estimates
Alta Equipment (ALTG) Reports Q3 Loss, Misses Revenue Estimates

Alta Equipment (ALTG) came out with a quarterly loss of $1.31 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.86 per share a year ago. These figures

Compared to Estimates, Peloton (PTON) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, Peloton (PTON) Q1 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Peloton (PTON) reported revenue of $550.8 million, down 6% over the same period last year. EPS came in at $0.03, compared to $0 in the year-ago quarter.

The

Huntsman (HUN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Huntsman (HUN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Huntsman (HUN) reported revenue of $1.46 billion, down 5.2% over the same period last year. EPS came in at -$0.03, compared to $0.10 in the year-ago quarter.

Zacks November View on Equity Markets
Zacks November View on Equity Markets

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of

Should the Hype for First Solar (FLSR) Stock Continue?
Should the Hype for First Solar (FLSR) Stock Continue?

Printing a fresh all-time high of $281 a share this week, First Solar FSLR stock regained bullish momentum after its Q3 report last Thursday.

The 20% rally over the last month has added to pleasant

indie Semiconductor, Inc. (INDI) Reports Q3 Loss, Misses Revenue EstimatesPhoto, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
indie Semiconductor, Inc. (INDI) Reports Q3 Loss, Misses Revenue Estimates

indie Semiconductor, Inc. (INDI) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.09 per share a year ago

Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.22 per share a year ago. These

Globalstar (GSAT) Reports Q3 Loss, Tops Revenue Estimates
Globalstar (GSAT) Reports Q3 Loss, Tops Revenue Estimates

Globalstar (GSAT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to break-even earnings per share a year ago. These figures

Cherry Hill Mortgage (CHMI) Q3 Earnings Miss EstimatesPhoto, wide shot, wide-angle lens,  Bank, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/3aa597ca-f944-4a9b-bf8d-3071f3b5a5c9.png
Cherry Hill Mortgage (CHMI) Q3 Earnings Miss Estimates

Cherry Hill Mortgage (CHMI) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.08 per share a year ago

Concentra Group (CON) Q3 Earnings and Revenues Top Estimates
Concentra Group (CON) Q3 Earnings and Revenues Top Estimates

Concentra Group (CON) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.37 per share a year ago. These

Globus Medical (GMED) Tops Q3 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Globus Medical (GMED) Tops Q3 Earnings and Revenue Estimates

Globus Medical (GMED) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.83 per share a year ago. These

Certara, Inc. (CERT) Q3 Earnings Surpass Estimates
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates

Certara, Inc. (CERT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.13 per share a year ago. These